Kolexia
Lavau-Denes Sandrine Médecine générale
Lavau-Denes Sandrine
Médecine générale
Hôpital Dupuytren
Limoges, France
77 Activités
179 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Tumeurs colorectales Métastase tumorale Récidive tumorale locale Adénocarcinome Carcinomes Tumeurs de la tête et du cou Thrombose Perte de poids

Collaborateurs

Voir plus
Venat Laurence
Venat Laurence
Hôpital Dupuytren, Limoges, France
Tubiana-Mathieu Nicole
Tubiana-Mathieu Nicole
Hôpital Dupuytren, Limoges, France
Deluche Elise
Deluche Elise
Hôpital Dupuytren, Limoges, France
Aparicio Thomas
Aparicio Thomas
Hôpital Avicenne, Bobigny, France

Industries

Voir plus
Lilly
2 collaboration(s)
Dernière en 2023
AstraZeneca
2 collaboration(s)
Dernière en 2022
Novartis
1 collaboration(s)
Dernière en 2022
GSK
1 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
StrateGlio: Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Essai Clinique (Centre Oscar-Lambret)   08 février 2024
1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer: Phase III Randomized Multicenter Trial Comparing Continued Maintenance Therapy With the Bevacizumab + Taxane Versus Bevacizumab + Substituting Exemestane in Patients With Metastatic Breast Cancer or Locally Advanced With Estrogen Receptor Positive and Having at Least a Stable Disease After 16 to 18 Weeks of Treatment With Bevacizumab + Taxane.
Essai Clinique (ARCAGY/ GINECO GROUP)   05 septembre 2023
CHACRY-1501: Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation (CHACRY-1501)
Essai Clinique (Centre Oscar-Lambret)   13 février 2023
Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?
BMC cancer   25 novembre 2022
175P Prosigna test for early breast cancer patients in real-life
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
Home-Based Physical Activity in Patients With Breast Cancer: During and/or After Chemotherapy? Impact on Cardiorespiratory Fitness. A 3-Arm Randomized Controlled Trial (APAC).
Integrative cancer therapies   18 août 2021
BIONADEGE: Phenotyping of Small Bowel Adenocarcinoma
Essai Clinique (Assistance publique – Hôpitaux de Paris)   12 janvier 2021
A double-blind phase III trial of immunomodulating nutritional formula during adjuvant chemoradiotherapy in head and neck cancer patients: IMPATOX.
The American journal of clinical nutrition   06 janvier 2021
Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohort.
International journal of cancer   04 janvier 2021
Comparison of 18FDG-PET/CT and conventional follow-up methods in colorectal cancer: A randomised prospective study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver   02 novembre 2020